FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282959095> ?p ?o ?g. }

• W4282959095 endingPage "5716" @default.
• W4282959095 startingPage "5716" @default.
• W4282959095 abstract "Abstract DIPG is an incurable and inoperable pediatric brain cancer in the ventral pons characterized by its complex mutational profile. Epigenetic mutations to H3K27M are seen in up to 81% of patients, resulting in the global loss of the repressive H3K27 trimethylation marker, increasing chromatin accessibility and deregulating gene expression. However, these epigenetic changes are often partnered by secondary mutations, with activating mutations and copy number gains observed in a wide variety of RTK genes and their associated signaling pathways. The combination of these two mutational paradigms results in the broad alteration of cellular and metabolic mechanisms, complicating the search for effective targeted therapeutic strategies. Copper, a metal ion essential for normal cellular function is known to be highly expressed in the pons, and influence ERK and PI3K/AKT signaling. Importantly, excess copper accumulation has been implicated in the pathogenesis of multiple neurological diseases and cancers. Copper chelation therapy is a clinically approved strategy for pediatric patients with Wilson’s Disease, known to improve their neurological symptoms, and is under investigation for use in a number of cancers. Therefore, we hypothesized copper chelation may be an effective therapeutic strategy for DIPG. Cytotoxicity assays using copper chelator tetraethylenepentamine (TEPA) demonstrated millimolar efficacy and synergized with mTOR inhibitor everolimus in a panel of DIPG cell lines, with H3-K27M mutant cell lines found to be more sensitive. Western blots were used to identify copper integrated pathways, with DIPG cell lines stimulated with sub-lethal copper concentrations demonstrating increased phosphorylated expression of ERK1/2, ERK5, AKT and p70SK61. TEPA reduced the phosphorylation of these markers compared to controls. Importantly, epigenetic mechanisms were sensitive to copper, as both copper stimulation and TEPA modulated H3K27 trimethylation, and TEPA decreased pro-expression H3K27 acetylation. In further blots examining epigenetic regulators, TEPA reduced the expression of EZH2, DNMT3B and DNMT1. RNA-sequencing analysis revealed TEPA downregulated genes involved in S-adenosylmethionine production metabolism, DNA regulation, cell cycle and mTORC signaling and specifically, EZH2, DNMT3B and DNMT1 expression. In vivo investigations demonstrated TEPA’s ability to improve survival in an orthotopic xenograft model, and via xenogen luminescence imaging complete tumor regression in 25% of treated mice. This study indicates copper directly impacts epigenetic and RTK mechanisms, and that their targeting through copper chelation agents represents a potential therapeutic strategy for DIPG, both as a single agent and in combination. Citation Format: Filip Michniewicz, Federica Saletta, Tayla Watkinson, Daniele Mercatelli, Federico M. Giorgi, Jessica Bell, Maria Tsoli, David Ziegler, Orazio Vittorio. Using copper chelating agents to simultaneously target epigenetic mechanisms and receptor tyrosine kinase (RTK) signaling in diffuse intrinsic pontine glioma (DIPG) [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 5716." @default.
• W4282959095 created "2022-06-17" @default.
• W4282959095 creator A5003165331 @default.
• W4282959095 creator A5015748071 @default.
• W4282959095 creator A5019801529 @default.
• W4282959095 creator A5034113263 @default.
• W4282959095 creator A5044359653 @default.
• W4282959095 creator A5046321083 @default.
• W4282959095 creator A5047341765 @default.
• W4282959095 creator A5070139120 @default.
• W4282959095 creator A5082316302 @default.
• W4282959095 date "2022-06-15" @default.
• W4282959095 modified "2023-09-24" @default.
• W4282959095 title "Abstract 5716: Using copper chelating agents to simultaneously target epigenetic mechanisms and receptor tyrosine kinase (RTK) signaling in diffuse intrinsic pontine glioma (DIPG)" @default.
• W4282959095 doi "https://doi.org/10.1158/1538-7445.am2022-5716" @default.
• W4282959095 hasPublicationYear "2022" @default.
• W4282959095 type Work @default.
• W4282959095 citedByCount "0" @default.
• W4282959095 crossrefType "journal-article" @default.
• W4282959095 hasAuthorship W4282959095A5003165331 @default.
• W4282959095 hasAuthorship W4282959095A5015748071 @default.
• W4282959095 hasAuthorship W4282959095A5019801529 @default.
• W4282959095 hasAuthorship W4282959095A5034113263 @default.
• W4282959095 hasAuthorship W4282959095A5044359653 @default.
• W4282959095 hasAuthorship W4282959095A5046321083 @default.
• W4282959095 hasAuthorship W4282959095A5047341765 @default.
• W4282959095 hasAuthorship W4282959095A5070139120 @default.
• W4282959095 hasAuthorship W4282959095A5082316302 @default.
• W4282959095 hasConcept C101544691 @default.
• W4282959095 hasConcept C104317684 @default.
• W4282959095 hasConcept C2778227246 @default.
• W4282959095 hasConcept C41091548 @default.
• W4282959095 hasConcept C502942594 @default.
• W4282959095 hasConcept C54355233 @default.
• W4282959095 hasConcept C62478195 @default.
• W4282959095 hasConcept C71924100 @default.
• W4282959095 hasConcept C75217442 @default.
• W4282959095 hasConcept C86554907 @default.
• W4282959095 hasConcept C86803240 @default.
• W4282959095 hasConcept C95444343 @default.
• W4282959095 hasConceptScore W4282959095C101544691 @default.
• W4282959095 hasConceptScore W4282959095C104317684 @default.
• W4282959095 hasConceptScore W4282959095C2778227246 @default.
• W4282959095 hasConceptScore W4282959095C41091548 @default.
• W4282959095 hasConceptScore W4282959095C502942594 @default.
• W4282959095 hasConceptScore W4282959095C54355233 @default.
• W4282959095 hasConceptScore W4282959095C62478195 @default.
• W4282959095 hasConceptScore W4282959095C71924100 @default.
• W4282959095 hasConceptScore W4282959095C75217442 @default.
• W4282959095 hasConceptScore W4282959095C86554907 @default.
• W4282959095 hasConceptScore W4282959095C86803240 @default.
• W4282959095 hasConceptScore W4282959095C95444343 @default.
• W4282959095 hasIssue "12_Supplement" @default.
• W4282959095 hasLocation W42829590951 @default.
• W4282959095 hasOpenAccess W4282959095 @default.
• W4282959095 hasPrimaryLocation W42829590951 @default.
• W4282959095 hasRelatedWork W1582629726 @default.
• W4282959095 hasRelatedWork W2315954560 @default.
• W4282959095 hasRelatedWork W2363685873 @default.
• W4282959095 hasRelatedWork W2947842923 @default.
• W4282959095 hasRelatedWork W3022564264 @default.
• W4282959095 hasRelatedWork W3146309432 @default.
• W4282959095 hasRelatedWork W3164029683 @default.
• W4282959095 hasRelatedWork W3197753362 @default.
• W4282959095 hasRelatedWork W3216750786 @default.
• W4282959095 hasRelatedWork W4226248319 @default.
• W4282959095 hasVolume "82" @default.
• W4282959095 isParatext "false" @default.
• W4282959095 isRetracted "false" @default.
• W4282959095 workType "article" @default.